Invention Grant
- Patent Title: Tetrazolones as a carboxylic acid bioisosteres
-
Application No.: US15233676Application Date: 2016-08-10
-
Publication No.: US09701647B2Publication Date: 2017-07-11
- Inventor: Matthew Duncton , Rajinder Singh
- Applicant: RIGEL PHARMACEUTICALS, INC.
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Bozicevic, Field & Francis LLP
- Agent Rudy J. Ng
- Main IPC: C07D257/04
- IPC: C07D257/04 ; A61K31/41 ; C07D403/06 ; C07D403/14 ; C07D401/12 ; C07D403/12 ; C07D401/10 ; C07D413/10 ; C07D501/16 ; C07D401/14 ; C07J43/00 ; C07D401/04 ; C07D487/04 ; C07D471/04 ; A61K31/4184 ; A61K31/4709 ; A61K31/4245 ; A61K31/546 ; A61K31/55 ; A61K31/496 ; A61K31/58 ; A61K31/506 ; A61K31/519
Abstract:
The present disclosure provides compounds that include a tetrazolone derivative of a carboxyl group of an active agent. This disclosure also relates to pharmaceutical compositions that include these compounds, methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds.
Public/Granted literature
- US20170129862A1 Tetrazolones as a Carboxylic Acid Bioisosteres Public/Granted day:2017-05-11
Information query
